[Antimicrobial resistant test of H. pylori]

Nihon Rinsho. 2001 Feb;59(2):291-5.
[Article in Japanese]

Abstract

The resistance of Helicobacter pylori (H. pylori) to antibiotics leaves great influence on treatment outcome. Agar and broth dilution techniques are difficult to perform and not practical. E-test has the advantage of allowing visualization of resistant subpopulations of bacteria within zones of inhibitions. We studied point mutation of 23s-rRNA gene for H. pylori strains. (74 clarithromycin (CAM)-resistant, 6 CAM-susceptible) The results of these assays were well correlated with these of E-test. The cure rate of triple therapy with metoronidazole (MTZ) for CAM-resistant H. pylori is 100%(11/11), and that with CAM for MTZ-resistant H. pylori is 94.4% (17/18). It is very difficult to eradicate CAM and MTZ-resistant H. pylori.

Publication types

  • Review

MeSH terms

  • Clarithromycin / pharmacology
  • Clarithromycin / therapeutic use
  • Drug Resistance, Microbial
  • Drug Therapy, Combination / therapeutic use
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / genetics
  • Humans
  • Metronidazole / pharmacology
  • Metronidazole / therapeutic use
  • Microbial Sensitivity Tests / methods*
  • Point Mutation
  • RNA, Ribosomal, 23S / genetics

Substances

  • RNA, Ribosomal, 23S
  • Metronidazole
  • Clarithromycin